Fifteen years ago, almost nobody outside a small circle of chemists and desert-dwelling curiosities had heard of 5-MeO-DMT. Today it sits at the center of the largest deal the psychedelic industry has ever seen, and its underground practitioners have become quiet celebrities, disgraced gurus, or both. The molecule itself is astonishing — a few seconds of inhalation and consciousness dissolves like sugar in hot water. Half an hour later, you are back. Somehow.

If you're researching plant medicine or psychedelics as a possible path through addiction, depression, or a life that's stopped making sense, you'll bump into this substance sooner or later. It's worth understanding what it actually is, where it comes from, and why the story around it has become one of the most tangled in the whole master-plants conversation.

What Exactly Is 5-MeO-DMT?

5-MeO-DMT is a tryptamine, chemically related to the DMT found in ayahuasca but distinct in its effects. It occurs naturally in a handful of plants and — famously — in the parotoid gland secretion of the Sonoran Desert toad, Incilius alvarius. Smoked or vaporized, the onset is almost instantaneous. Most reports describe an experience that isn't really an experience at all in the usual sense: no visions, no narrative, no self to have visions. Just a kind of shattering.

People who have done a lot of psychedelics tend to speak about 5-MeO with unusual carefulness. Ayahuasca might show you your childhood. Psilocybin might reorganize your relationship with your mother. 5-MeO tends to dismantle the very frame those experiences would sit inside. That's why, in traditional and underground circles, it's the medicine you work up to — not the one you start with.

And yet, because it's so brief, it fits neatly into a pharmaceutical clinical trial slot. That paradox is where most of the current drama lives.

The Sonoran Toad and a Genuinely Weird Supply Chain

Here's the part nobody in a fancy ceremony room particularly wants to think about. The dried secretion being sold as "toad" or "bufo" mostly comes from wild-caught toads in northern Mexico. These animals spend three-quarters of the year buried underground, invisible. When the summer rains come, they erupt from the desert in a short, frantic mating window — and that's when people show up with buckets and sacks.

Journalist Kimon de Greef, whose reporting maps this trade in painful detail, describes it as one of the strangest niche biotrades on earth. Rural collectors in impoverished parts of Sonora catch toads for a few dollars a day. Middlemen dry the secretion. Buyers move it north. The trade sits inside a landscape that is also cartel territory, which means you can't just wander around asking questions without consequences. Conservation biologists are increasingly worried the harvest isn't sustainable, particularly as global demand grows.

Synthetic 5-MeO-DMT exists and is, molecule-for-molecule, identical. Many underground facilitators have quietly switched to it, both for ethical reasons and because it's easier to dose precisely. If you're considering a session, this is a fair question to ask a facilitator directly: where does your medicine come from? An answer that dodges the question tells you something.

Octavio Rettig and the Cult of the Toad Guru

You can't discuss modern 5-MeO without discussing Octavio Rettig, the Mexican doctor who — depending on who you ask — either single-handedly popularized toad medicine or single-handedly gave it a black eye. His origin story was irresistible: recovering from crack addiction using toad, then bringing the medicine to a meth-addicted Indigenous community in Sonora, then reframing it as a lost ancestral practice.

He toured the world. He filled ceremony rooms. He built a movement. And then a growing chorus of former participants and colleagues began describing something much darker: coerced dosing, physical abuse, taser-like devices used on people in altered states, deaths in his care. The pattern that unfolded around him is one that anyone researching a psychedelic retreat should study, because it's not unique to him.

The lesson isn't "avoid toad." The lesson is that charismatic founder-figures with unquestioned authority over unconscious clients are a structural risk, full stop. Ask about lineage, but also ask about accountability. Who supervises the facilitator? What happens when something goes wrong? Is there a screening process, or does the money change hands and everyone crosses their fingers?

Big Pharma Enters the Room

Meanwhile, on a completely different track, biotech companies have been quietly developing 5-MeO-DMT as a fast-acting antidepressant. The pitch to regulators is clean: powerful effects, short duration, potentially transformative for treatment-resistant depression. When Eli Lilly moved to acquire one of the leading developers recently, it signaled that the world's largest pharmaceutical company now considers this obscure toad molecule a serious commercial asset.

There's real logic to the pharma approach. Clinical trials generate the kind of safety data the underground simply doesn't have. Standardized dosing reduces the risk of catastrophic outcomes. Regulatory approval, if it comes, would make treatment legally accessible to millions of people who will never fly to Mexico.

But the tensions are obvious. To satisfy the FDA, the drug has to demonstrate an effect largely independent of therapy — because therapy is hard to standardize and blind. That pushes trials toward minimal psychological support. And 5-MeO, according to nearly everyone who has worked with it seriously, is a molecule that benefits from a great deal of psychological support. Trial monitors reportedly swap stories at conferences about participants writhing, screaming, running around the room. Sometimes those same participants describe the trip afterward as the best experience of their lives. Sometimes they don't.

What Actually Happens Weeks and Months Later?

This is the question that gets under-asked, and it's arguably the most important one for anyone considering a session. The acute experience is brief. The integration can take months, sometimes longer. People routinely describe feeling reborn in the days after a session — and then, weeks later, finding themselves back in the exact life circumstances that contributed to their suffering in the first place.

Some clinicians warn that this glimpse-and-return dynamic can actually deepen depression for certain people. You've seen something profound. You can't get back to it. Ordinary life feels smaller than it did before. Without adequate support, that gap can become its own wound.

What tends to help:

• A pre-session period of honest self-inventory — what are you actually hoping to shift, and why now?
• A facilitator who screens you carefully and doesn't push you toward a session you're ambivalent about
• Real integration support afterward, ideally with a therapist familiar with non-ordinary states
• Community — other people who've done similar work and can normalize the strange months that follow
• Patience with the timeline; the meaningful changes rarely arrive on the schedule you expected

None of this is glamorous. None of it fits on a retreat brochure. It's also what separates the people who come out of these experiences better from the people who come out of them worse.

How to Think About This If You're Considering It

A few honest points that don't usually appear in the marketing materials. 5-MeO-DMT is not for beginners. If you've never sat with a psychedelic before, this is not where to start. Ayahuasca, psilocybin, or even a well-facilitated ketamine session will teach you more about how you respond to non-ordinary states, at a pace that leaves room to learn.

Screening matters. People with certain cardiovascular conditions, serotonergic medications, or personal or family histories of psychosis are at genuine risk. A facilitator who doesn't ask detailed medical and psychiatric questions is a facilitator you should walk away from.

The setting matters more than the setting's Instagram feed. A quiet, boring, safe room with a competent sitter beats a stunning jungle location with a magnetic guru every single time. Master plants and their synthetic cousins are not gentle teachers, and 5-MeO-DMT is arguably the least gentle of the lot.

Finally, ask yourself why you want this specifically. If the answer is "I've heard it's the most powerful," that's a red flag, not a reason. The strongest medicine isn't necessarily the right medicine for you at this moment. Sometimes the slower path — ayahuasca ceremonies over several years, or psilocybin work with a skilled therapist — does more lasting good than the peak experience you can't quite come back from.

If, after all that, you're still curious, take your time. Talk to people who have done it. Read the harder, less flattering reports as well as the ecstatic ones. For readers who want to explore the field further, a curated selection of psychedelic and plant-medicine retreats — including centers working with 5-MeO-DMT and related master plants — can be browsed on our marketplace here. Whatever you decide, decide slowly. This particular molecule doesn't reward hurry.